WHO statement on clasification Classification of Omicron : SARS-CoV-2 as Variant of Concern

WHO statement:

Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern

The Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) is an independent group of experts that periodically monitors and evaluates the evolution of SARS-CoV-2 and assesses if specific mutations and combinations of mutations alter the behaviour of the virus. The TAG-VE was convened on 26 November 2021 to assess the SARS-CoV-2 variant: B.1.1.529.

The B.1.1.529 variant was first reported to WHO from South Africa on 24 November 2021. The epidemiological situation in South Africa has been characterized by three distinct peaks in reported cases, the latest of which was predominantly the Delta variant. In recent weeks, infections have increased steeply, coinciding with the detection of B.1.1.529 variant. The first known confirmed B.1.1.529 infection was from a specimen collected on 9 November 2021.

Problem, Solution, SitRep, or ?: 

Moderna says Omicron represents a "significant potential risk" to vaccine and natural-induced immunity

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

U.S., EU restrict travel from southern Africa because of new COVID variant named "omicron"

Belgium, Israel detect first cases of new COVID-19 variant.

Ana;ysis: The debate over the definition of "fully vaccinated--whether it mean a booster

A flood of covid patients causes ‘almost unmanageable’ strain in Michigan as cases rise nationwide

BioNTech says it will know in 2 weeks whether the COVID-19 vaccine it developed with Pfizer works against the new variant discovered in southern Africa

Fauci says U.S. must study data before deciding on travel ban over new COVID-19 variant

Analysis: BBC and AP analysis of the new variant.

WHO cautions against imposing travel restrictions due to new variant

Nations takes action as new variant emerges in southern Africa

BRUSSELS (AP) — A slew of nations moved to stop air travel from southern Africa on Friday, and stocks plunged in Asia and Europe in reaction to news of a new, potentially more transmissible COVID-19 variant.

Problem, Solution, SitRep, or ?: 

A new Covid-19 variant could show immune evasion and enhanced transmissibility, South African scientists warn

SARS-CoV-2 antibody levels predict COVID vaccine efficacy, study finds

 

SARS-CoV-2 antibody concentrations predict COVID-19 vaccine effectiveness, with higher levels correlating with greater protection, according to an ongoing US phase 3 clinical trial yesterday in Science.

A team led by researchers from Fred Hutchinson Cancer Research Center in Seattle evaluated 30,420 adult recipients of the Moderna mRNA COVID-19 vaccine at 99 centers for neutralizing and binding antibodies as correlates of risk for, and protection against, infection.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Do fully vaccinated persons who also had COVID need a booster?

CEPI to expand COVID-19 vaccine testing network to assess countermeasures to other epidemic threats

Pages

Subscribe to Global RSS
howdy folks
Page loaded in 1.208 seconds.